In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 0.04 below Cannabis Global Inc. average.

Within Biotechnology & Pharmaceuticals industry 207 other companies have achieved higher Quick Ratio than Cannabis Global in third quarter 2022. While Quick Ratio total ranking in the third quarter 2022 has deteriorated compared to the prior quarter from 4988 to 5752.

Explain Quick Ratio?
How much Cash & cash equivalents CBGL�s has?
What are CBGL�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CBGL Quick Ratio	(May 31 2022) Q3	(Feb 28 2022) Q2	(Nov 30 2021) Q1	(Aug 31 2021) Q4	(May 31 2021) Q3
Y / Y Current Liabilities Change	12.91 %	-14.7 %	47.75 %	361.93 %	91.85 %
Y / Y Cash & cash equivalent Change	-2.77 %	332.29 %	43.32 %	323.71 %	215.79 %
Quick Ratio MRQ	0.04	0.1	0.02	0	0.05
CBGL's Total Ranking	# 5752	# 4988	# 530	# 6115	#
Seq. Current Liabilities Change	2.55 %	-1.75 %	-30.63 %	61.54 %	-22.53 %
Seq. Cash & cash equivalent Change	-57.37 %	535.71 %	137.9 %	-84.92 %	89.55 %

Quick Ratio third quarter 2022 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 208
Healthcare Sector	# 1251
Overall Market	# 5752

Quick Ratio Statistics
High	Average	Low
72.13	6.04	0
(Aug 31 2011)		(Aug 31 2020)

Financial Statements
Cannabis Global's Current Liabilities	$ 6 Millions	Visit CBGL's Balance sheet
Cannabis Global's Cash & cash equivalent	$ 0 Millions	Visit CBGL's Balance sheet
Source of CBGL's Sales		Visit CBGL's Sales by Geography

Cumulative Cannabis Global's Quick Ratio

CBGL's Quick Ratio for the trailling 12 Months

CBGL Quick Ratio	(May 31 2022) 12 Months	(Feb 28 2022) 12 Months	(Nov 30 2021) 12 Months	(Aug 31 2021) 12 Months	(May 31 2021) 12 Months
Y / Y Current Liabilities TTM Growth	46.11 %	65.64 %	164.46 %	291.56 %	290.73 %
Y / Y Cash & cash equivalent TTM Growth	107.47 %	235.37 %	71.41 %	63.51 %	5.96 %
Quick Ratio TTM	0.04	0.04	0.02	0.02	0.03
Total Ranking TTM	# 5674	# 5672	# 112	# 5595	#
Seq. Current Liabilities TTM Growth	2.67 %	-3.77 %	7.76 %	37.24 %	16.4 %
Seq. Cash & cash equivalent TTM Growth	-0.73 %	86.06 %	5.62 %	6.35 %	60.47 %

Quick ratio ranking by company, industry and sector >> Back to CBGL Financial Strength Comparisons >> Go to Compare CBGL Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q3 2022 to $6.11 millions, cumulative Quick Ratio remained unchanged at 0.04 below the Cannabis Global Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 196 other companies have achieved higher Quick Ratio than Cannabis Global. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2022 from 5672 to 5674.

Explain Quick Ratio?
How much Cash & cash equivalents CBGL�s has?
What are CBGL�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 197
Healthcare Sector	# 1219
Within the Market	# 5674

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.88	0.62	0.01
(May 31 2018)		(Aug 31 2021)

Companies with similar Quick Ratio in the quarter ending May 31 2022, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	May 31 2022 MRQ Cash & cash equivalent	May 31 2022 MRQ Current Liabilities
Mosaic Immunoengineering Inc	0.06	$ 0.206 Millions	$ 3.322 Millions
Cannabis Global Inc.	0.04	$ 0.261 Millions	$ 6.114 Millions
Peak Bio Inc	0.03	$ 0.045 Millions	$ 1.484 Millions
Zeo Scientifix Inc	0.02	$ 0.138 Millions	$ 6.853 Millions
Point Of Care Nano technology Inc	0.01	$ 0.003 Millions	$ 0.213 Millions
Prokidney Corp	0.01	$ 0.108 Millions	$ 7.934 Millions

Date modified: 2026-09-08T15:10:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.